Surgical treatment of pulmonary metastases from soft tissue sarcomas: A retrospective study in the Netherlands
✍ Scribed by Albert N. van Ceel; Frits Van Coevorden; Jan D. Blankensteijn; Harald J. Hoekstra; Bart Schuurman; Erik D. M. Bruccink; Carlo W. Taat; Evert B. M. Theunissen
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 518 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Sixty‐seven of 87 patients with soft tissue sarcoma underwent complete resection of the metastases in the lung. In this retrospective study, follow‐up was for a median of 24 months. The 5‐year overall, crude, and disease‐free survival was 38%, 45%, and 41%, respectively. Twentyseven (40%) patients developed a recurrence in the lung. Of the six prognostic variables, the only factor significantly related to disease‐free survival was grade. It is concluded that surgery for lung metastases of soft tissue sarcoma should be considered as standard therapy when preoperative evaluation predicts a complete resection. By adding chemotherapy to surgery, an improvement of prognosis probably can be achieved. © 1994 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND. The benefit of chemotherapy in the treatment of primary soft‐tissue sarcoma (STS) is controversial. To the authors' knowledge, few studies to date have examined the effect of chemotherapy in patients undergoing pulmonary resection for metastatic STS of the extremity. ##
Several reports have shown a prolonged survival after surgical treatment of pulmonary metastases from soft tissue sarcomas. However, it is still unclear which prognostic factors predict a favorable outcome. Series are not comparable and the data are conflicting. Therefore, a multi-institutional stud
## Background: Standard therapy for pediatric nonrhabdomyosarcoma soft tissue sarcomas (pnrsts) consists of surgical resection with or without radiotherapy. the role of chemotherapy in the treatment of these tumors has not yet been defined. we investigated the efficacy and toxicity of an ifosfamide
## Abstract ## Background and Objectives This study reviews incidence and risk factors for venous thromboembolism (VTE) in bone/soft‐tissue sarcoma patients prior to the initiation of Surgical Care Improvement Program (SCIP) measures in October 2009. ## Methods A retrospective chart review ident